Institutional investors purchased a net $133.1 thousand shares of MDCO during the quarter ended June 2017 and now own 128.25% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STATE STREET GLOBAL ADVISORS LTD... Bought 101.00 shares of Medicines Co
BAYSTATE WEALTH MANAGEMENT LLC Bought 99.00 shares of Medicines Co